Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children

NCT03943888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia, General
Neuromuscular Blockade

Interventions

DRUG: Sugammadex Injection 2mg/kg
DRUG: Sugammadex Injection 4mg/kg
DRUG: Sugammadex Injection 8mg/kg
DRUG: Neuromuscular reversal agent injection

Sponsor

Seoul National University Hospital

Collaborators

[object Object]